SELLAS Life Sciences Group, Inc. (SLS)
(Real Time Quote from BATS)
$1.90 USD
+0.03 (1.60%)
Updated Oct 6, 2025 03:28 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, SELLAS Life Sciences Group, Inc. has a market cap of $196.91M, which represents its share price of $1.87 multiplied by its outstanding shares number of 105.30M. As a small-cap company, SLS's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
SLS 1.90 +0.03(1.60%)
Will SLS be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for SLS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SLS
SELLAS Life Sciences Group (SLS) Upgraded to Buy: What Does It Mean for the Stock? (Revised)
Galena Biopharma (SLS) Upgraded to Buy: What Does It Mean for the Stock?
SLS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for SLS
Is SLS likely to continue higher? Crossed Above 20 Day Moving Average shows up after surging 9.36%
Is SLS gaining bearish strength? 20 Day Moving Average Resistance shows up after gaining 0.63%
SELLAS Extends Times Square Sublease Agreement
Is SLS gaining bearish strength? 20 Day Moving Average Resistance shows up after climbing 4.97%
Bullish Engulfing appears for SLS after 3.21% move